Skip to main content
Log in

Efficacy of Curcumin on Cognitive Function Scores in Women with Premenstrual Syndrome and Dysmenorrhea: A Triple-Blind, Placebo-Controlled Clinical Trial

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To assess the efficacy of a curcumin supplementation on cognitive abilities in women suffering from premenstrual syndrome (PMS) and dysmenorrhea.

Methods

A randomized, triple-blind, placebo-controlled trial was conducted from December 2019 to March 2020. A total of 124 women who had both PMS and dysmenorrhea were enrolled, and were equally and randomly assigned to the curcumin group or placebo group, 62 cases in each. Each subject received either a capsule containing 500 mg of curcuminoid, or a placebo daily, for 10 days (7 days before and until 3 days after the onset of menstrual bleeding) over 3 menstrual cycles. The cognitive abilities questionnaire was used to measures cognitive functions in 7 specific areas. Adverse reactions were monitored during and after the trial in both groups.

Results

Administration of curcumin was associated with a significant increase in memory score (P=0.002), inhibitory control and selective attention (P=0.020), and total cognitive ability task (P=0.024). In addition, significant increments were found in scores of memory (3.5±3.1 vs. 0.4±3.8 in the curcumin and placebo groups, respectively; P=0.035), inhibitory control and selective attention (3.0±3.7 vs. 0.4±3.7; P=0.027) and total cognitive abilities (8.3±12.3 vs. 2.2±12.4; P=0.025) in the curcumin group versus placebo groups. Curcumin was safe and well-tolerable in current clinical trial.

Conclusion

Curcumin has a beneficial efficacy on cognitive function scores in women with PMS and dysmenorrhea, with improvements in memory, inhibitory control and selective attention. (Registration No. IRCT20191112045424N1, available at: https://www.irct.ir)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. IŞIK H, Ergöl Ş, AYNIOĞLU Ö, Şahbaz A, Kuzu A, Uzun M. Premenstrual syndrome and life quality in Turkish health science students. Turk J Med Sci 2016;46:695–701.

    Article  PubMed  Google Scholar 

  2. Joshi T, Kural M, Agrawal DP, Noor NN, Patil A. Primary dysmenorrhea and its effect on quality of life in young girls. Int J Med Sci Public Health 2015;4:381–385.

    Article  Google Scholar 

  3. McCracken LM, Iverson GL. Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage 2001;21:392–396.

    Article  CAS  PubMed  Google Scholar 

  4. Farage MA, Osborn TW, MacLean AB. Cognitive, sensory, and emotional changes associated with the menstrual cycle: a review. Arch Gynecol Obstet 2008;278:299.

    Article  PubMed  Google Scholar 

  5. Bernardi M, Lazzeri L, Perelli F, Reis FM, Petraglia F. Dysmenorrhea and related disorders. F1000 Res 2017;6:1645.

    Article  Google Scholar 

  6. Altman G, Cain KC, Motzer S, Jarrett M, Burr R, Heitkemper M. Increased symptoms in female IBS patients with dysmenorrhea and PMS. Gastroenterol Nurs 2006;29:4–11.

    Article  PubMed  Google Scholar 

  7. Keenan P, Stern RA, Janowsky DS, Pedersen CA. Psychological aspects of premenstrual syndrome I: cognition and memory. Psychoneuroendocrinology 1992;17:179–187.

    Article  CAS  PubMed  Google Scholar 

  8. Jang SH, Kim DI, Choi MS. Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review. BMC Complement Altern Med 2014;14:11.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. J Popul Ther Clin Pharmacol 2009;16:e407–e429.

    Google Scholar 

  10. Zheng L, Chen PF, Dai WC, Zheng ZQ, Wang HL. Curcumin alleviates hyperandrogenism and promotes follicular proliferation in polycystic ovary syndrome rats: insights on IRS1/PI3K/GLUT4 and PTEN modulations. Chin J Integr Med 2022;28:1088–1095.

    Article  CAS  PubMed  Google Scholar 

  11. Esmaily H, Sahebkar A, Iranshahi M, Ganjali S, Mohammadi A, Ferns G, et al. An investigation of the effects of curcumin on anxiety and depression in obese individuals: a randomized controlled trial. Chin J Integr Med 2015;21:332–338.

    Article  CAS  PubMed  Google Scholar 

  12. Lopresti AL. Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies. J Psychopharmacol 2017;31:287–302.

    Article  CAS  PubMed  Google Scholar 

  13. Thiyagarajan M, Sharma SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 2004;74:969–985.

    Article  CAS  PubMed  Google Scholar 

  14. Gera M, Sharma N, Ghosh M, Huynh DL, Lee SJ, Min T, et al. Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget 2017;8:66680.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Dickerson LM, Mazyck PJ, Hunter MH. Premenstrual syndrome. Am Fam Physician 2003;67:1743–1752.

    PubMed  Google Scholar 

  16. Khayat S, Fanaei H, Kheirkhah M, Moghadam ZB, Kasaeian A, Javadimehr M. Curcumin attenuates severity of premenstrual syndrome symptoms: a randomized, double-blind, placebo-controlled trial. Complemet Ther Med 2015;23:318–324.

    Article  Google Scholar 

  17. Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening tool (PSST) for clinicians. Arch Womens Ment Health 2003;6:203–209.

    Article  CAS  PubMed  Google Scholar 

  18. Ayadilord M, Mahmoudzadeh S, Hoseini ZS, Askari M, Rezapour H, Saharkhiz M, et al. Neuropsychological function is related to irritable bowel syndrome in women with premenstrual syndrome and dysmenorrhea. Arch Gynecol Obstet 2020;302:915–923.

    Article  PubMed  Google Scholar 

  19. Crichton N. Visual analogue scale (VAS). J Clin Nurs 2001;10:706.

    Google Scholar 

  20. Nejati V. Cognitive abilities questionnaire: development and evaluation of psychometric properties. Adv Cogn Sci 2013;15:11–19.

    Google Scholar 

  21. Ahmadnezhad M, Asadi Z, Miri HH, Ebrahimi-Mamaghani M, Ghayour-Mobarhan M, Ferns GA. Validation of a short semi-quantitative food frequency questionnaire for adults: a pilot study. J Nutrit Sci Dietet 2017;3:49–55.

    Google Scholar 

  22. Balık G, Üstüner I, Kağıtcı M, Şahin FK. Is there a relationship between mood disorders and dysmenorrhea? J Pediatr Adolesc Gynecol 2014;27:371–374.

    Article  PubMed  Google Scholar 

  23. Le J, Thomas N, Gurvich C. Cognition, the menstrual cycle, and premenstrual disorders: a review. Brain Sci 2020;10:198.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Freeman E, Rickels K, Sondheimer S. Premenstrual symptoms and dysmenorrhea in relation to emotional distress factors in adolescents. J Psychosom Obstet Gynaecol 1993;14:41–50.

    Article  CAS  PubMed  Google Scholar 

  25. Liu D, Wang Z, Gao Z, Xie K, Zhang Q, Jiang H, et al. Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress. Behav Brain Res 2014;271:116–121.

    Article  CAS  PubMed  Google Scholar 

  26. Minzenberg MJ, Carter CS. Developing treatments for impaired cognition in schizophrenia. Trends Cogn Sci 2012;16:35–42.

    Article  PubMed  Google Scholar 

  27. Naismith SL, Rogers NL, Lewis SJ, Diamond K, Terpening Z, Norrie L, et al. Sleep disturbance in mild cognitive impairment: differential effects of current and remitted depression. Acta Neuropsychiatr 2011;23:167–172.

    Article  PubMed  Google Scholar 

  28. Small GW, Siddarth P, Li Z, Miller KJ, Ercoli L, Emerson ND, et al. Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: a double-blind, placebo-controlled 18-month trial. Am J Geriatr Psychiatry 2018;26:266–277.

    Article  PubMed  Google Scholar 

  29. Frautschy S, Hu W, Kim P, Miller S, Chu T, Harris-White M, et al. Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology. Neurobiol Aging 2001;22:993–1005.

    Article  CAS  PubMed  Google Scholar 

  30. Rui P, Sheng Q, Lu DX, Jun D. Curcumin improves learning and memory ability and its neuroprotective mechanism in mice. Chin Med J 2008;121:832–839.

    Article  Google Scholar 

  31. Vaynman S, Ying Z, Gomez-Pinilla F. Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci 2004;20:2580–2590.

    Article  PubMed  Google Scholar 

  32. Wu A, Ying Z, Gomez-Pinilla F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp Neurol 2006;197:309–317.

    Article  CAS  PubMed  Google Scholar 

  33. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001;21:8370–8377.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Derman O, Kanbur NÖ, Tokur TE, Kutluk T. Premenstrual syndrome and associated symptoms in adolescent girls. Eur J Obstet Gynecol Reprod Biol 2004;116:201–206.

    Article  PubMed  Google Scholar 

  35. Huang HC, Lin CJ, Liu WJ, Jiang RR, Jiang ZF. Dual effects of curcumin on neuronal oxidative stress in the presence of Cu (II). Food Chem Toxicol 2011;49:1578–1583.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

We are grateful to all study participants.

Author information

Authors and Affiliations

Authors

Contributions

AB conducted all analyses and drafted the manuscript. AJ and SK coordinated the fieldwork of the study. MA and AB provided methodological feedback. AJ and GF supervised the overall research project and helped to draft the manuscript. All of the authors have read and confirmed the final manuscript.

Corresponding author

Correspondence to Afsane Bahrami.

Ethics declarations

The authors declare that they have no conflict of interest.

Additional information

Supported by Grants from Birjand University of Medical Sciences, Birjand, Iran (No. 5109)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bahrami, A., Jafari-Nozad, A.M., Karbasi, S. et al. Efficacy of Curcumin on Cognitive Function Scores in Women with Premenstrual Syndrome and Dysmenorrhea: A Triple-Blind, Placebo-Controlled Clinical Trial. Chin. J. Integr. Med. 29, 387–393 (2023). https://doi.org/10.1007/s11655-023-3732-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-023-3732-3

Keywords

Navigation